Takeda Pharmaceutical’s oveporexton is designed to treat the root cause of narcolepsy. Statistically significant Phase 3 results for the twice daily pill were presented Monday during the World Sleep 2025 Congress in Singapore. The post Takeda Is Waking Up the Narcolepsy Market With First-in-Class Drug, But Alkermes Is on Its Heels appeared first on MedCity…
WeightWatchers’ new menopause program provides support from menopause-trained clinicians, along with workshops, fitness guidance and access to prescriptions when needed. The post WeightWatchers Introduces New Menopause Program appeared first on MedCity News.
Despite achieving statistically signficant improvement in progression-free survival in North American and European patients, Summit’s drug ivonescimab fell short of the other Phase 3 goal measuring overall survival. It’s the first Phase 3 readout for an emerging class of bispecific antibodies that treat cancer by blocking two targets, PD-1 and VEGF. The post Summit Lung…
Testosterone deficiency deserves the same attention we give to any other age-related health concern. Providers can play a big role by starting the conversation when a patient brings up things like low energy, mood changes or reduced sex drive. The post Why Hormone Health Should Be A Standard Part Of Men’s Healthcare appeared first on…
The bill clarifies very specific patient protections and codifies a Patient’s Bill of Rights, all of which would ensure that individuals receiving supplemental oxygen in the home – and their suppliers – understand requirements around equipment, communications, and care options. The post SOAR Act Would Help Individuals Relying on Oxygen Thrive appeared first on MedCity…
[Sponsored] A new eBook from Veradigm highlights operational best practices and emerging trends at this transformational time in healthcare. The post How Can Payers Use Tech to Their Best Advantage? appeared first on MedCity News.
A judge temporarily blocked key parts of a Trump rule that would have restricted access to Marketplace coverage, marking a legal victory for Democrats and healthcare advocates who argued the rule would cause widespread coverage losses and violated federal law. The post Why a US Judge Paused Several Provisions of the Marketplace Rule appeared first…
In the race to modernize US healthcare, Donald Trump’s new health data-sharing initiative risks giving Big Tech a stranglehold over patient information, and locking out the very startups that fuel innovation. The post Trump’s Health Data Plan Could Hand Big Tech The Keys —And Lock Out Startups appeared first on MedCity News.
We need a national strategy to expand access to palliative care, train the next generation of clinicians, and build the infrastructure that allows for scalable, tech-enabled, patient-centered delivery. The post The Hidden Crisis in Serious Illness Care and How We Fix It appeared first on MedCity News.
Hello Patient’s Series A round was led by Scale Venture Partners and included participation from 8VC, Bling Capital, Max Ventures, Remus Capital and FirstLook Partners. The post Hello Patient Secures $22.5M for Conversational AI Solution appeared first on MedCity News.